NFKB1 and psoriasis: In parallel, IDMF suppresses NF-κB, AP-1, IRF1, and STAT-linked pathways, thereby downregulating IL-17A, IL-23A, IL-36G, IFN-γ, and other psoriasis-associated cytokines at their transcriptional origins.